78 related articles for article (PubMed ID: 9597477)
1. [Immunohistochemical study of the paranasal sinus mucosa of patients being treated with macrolide antibiotics--effects of antigen-presenting cells on the expression of a costimulator].
Iino Y; Miyazawa T; Shiga J
Jpn J Antibiot; 1998 Jan; 51 Suppl A():25-6. PubMed ID: 9597477
[No Abstract] [Full Text] [Related]
2. [Effect of macrolide antibiotics on VEGF production in nasal mucosa fibroblasts cultured under hypoxic conditions].
Ushikai M; Sun D; Ohori J; Matsune T; Kurono Y
Jpn J Antibiot; 2003 Apr; 56 Suppl A():89-90. PubMed ID: 14679755
[No Abstract] [Full Text] [Related]
3. Effect of macrolides on the expression of HLA-DR and costimulatory molecules on antigen-presenting cells in nasal polyps.
Iino Y; Sasaki Y; Kojima C; Miyazawa T
Ann Otol Rhinol Laryngol; 2001 May; 110(5 Pt 1):457-63. PubMed ID: 11372931
[TBL] [Abstract][Full Text] [Related]
4. [Cell surface antigens on inflammatory cells in the paranasal mucosa of patients after macrolide therapy].
Miyazawa T; Iino Y
Nihon Jibiinkoka Gakkai Kaiho; 1997 Jun; 100(6):671-7. PubMed ID: 9248279
[TBL] [Abstract][Full Text] [Related]
5. [Possible potentiation of phenprocoumon by clarithromycin and roxithromycin].
Meyboom RH; Heere FJ; Egberts AC; Lastdrager CJ
Ned Tijdschr Geneeskd; 1996 Feb; 140(7):375-7. PubMed ID: 8628425
[TBL] [Abstract][Full Text] [Related]
6. [Study on the effects of macrolide antibiotics on the expression of B7-1, B7-2, and CD40 on epidermal Langerhans cells].
Salgado CG; Nakamura S; Komiyane M; Tamaoki K
Jpn J Antibiot; 1998 Jan; 51 Suppl A():27-8. PubMed ID: 9597478
[No Abstract] [Full Text] [Related]
7. [Effect of macrolide antibiotics on ion transport of nasal mucosal epithelium].
Ikeda K; Furukawa M; Takasaka T; Yamatani M
Jpn J Antibiot; 1997 Mar; 50 Suppl A():60-1. PubMed ID: 9678982
[No Abstract] [Full Text] [Related]
8. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy.
Suzuki H; Ikeda K; Honma R; Gotoh S; Oshima T; Furukawa M; Takasaka T
ORL J Otorhinolaryngol Relat Spec; 2000; 62(3):121-7. PubMed ID: 10810255
[TBL] [Abstract][Full Text] [Related]
10. [Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics].
Fujita K; Shimizu T; Usui T; Majima Y; Sakakura Y
Jpn J Antibiot; 1998 Jan; 51 Suppl A():124-7. PubMed ID: 9597505
[No Abstract] [Full Text] [Related]
11. [Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation].
Sakata K; Inoue K; Shibazaki M; Tanaka K; Sakamoto Y; Matsuo H
Jpn J Antibiot; 1997 Mar; 50 Suppl A():32-4. PubMed ID: 9597435
[No Abstract] [Full Text] [Related]
12. [Study of suppression of neutrophil functions and prevention of vascular endothelial injury by macrolide antibiotics].
Hikariyama T; Hidaka T; Furuno T; Hara N; Ishibashi B
Jpn J Antibiot; 1998 Jan; 51 Suppl A():9-11. PubMed ID: 9597473
[No Abstract] [Full Text] [Related]
13. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
Suzuki M; Asano K; Yu M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2002 Aug; 11(4):235-44. PubMed ID: 12396475
[TBL] [Abstract][Full Text] [Related]
14. [Neutrophilic migration caused by nasal secretion collected from patients with chronic paranasal sinusitis].
Shimomura A; Suzuki H; Ikeda K; Takasaka T
Jpn J Antibiot; 1997 Mar; 50 Suppl A():72-4. PubMed ID: 9597443
[No Abstract] [Full Text] [Related]
15. [Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics].
Suzuki H; Shimomura A; Ikeda K; Furukawa M; Wataya H; Takasaka T
Jpn J Antibiot; 1997 Mar; 50 Suppl A():68-70. PubMed ID: 9597442
[No Abstract] [Full Text] [Related]
16. [Effects of 14-member cyclic macrolide compounds on rat leukocyte chemotaxis].
Obori M; Otoguro K; Suzuki K; Sunazuka K; Kobata R; Iwai J; Omura S
Jpn J Antibiot; 2000 Jan; 53 Suppl A():85-8. PubMed ID: 10756460
[No Abstract] [Full Text] [Related]
17. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
18. [Suppressive activity of a macrolide antibiotic, roxithromycin, and its metabolites on co-stimulatory molecule expression].
Suzuki M; Asano K; Susaki H
Jpn J Antibiot; 2001 Dec; 54 Suppl C():91-3. PubMed ID: 12575428
[No Abstract] [Full Text] [Related]
19. [Actions of macrolide antibiotics on alginate production by Pseudomonas aeruginosa].
Kobayashi O; Ota M; Watanabe H; Kobayashi H
Jpn J Antibiot; 1997 Mar; 50 Suppl A():95-101. PubMed ID: 9597455
[No Abstract] [Full Text] [Related]
20. Anti-inflammatory activity of macrolide antibiotics.
Ianaro A; Ialenti A; Maffia P; Sautebin L; Rombolà L; Carnuccio R; Iuvone T; D'Acquisto F; Di Rosa M
J Pharmacol Exp Ther; 2000 Jan; 292(1):156-63. PubMed ID: 10604943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
